Save your place

Sign in to WhoBought

Please try again later.

Ray Dalio's Adaptive Biotechnologies Corporation (ADPT) position

Yes: as of Q1 2026, Ray Dalio holds 90K shares of ADPT worth an amount we cannot price (0.0% of the disclosed portfolio). Last quarter the position was reduced by 66.2%. First disclosed Q3 2025.
View full portfolio →
Current value
an amount we cannot price
Shares held
90K
% of portfolio
0.0%
Quarter-end price
No quarter-end price available

Average buy price is hidden here because at least one covered purchase quarter has no usable local mean price.

ADPT price vs Dalio's position

Dates
$20$22$24← Earlier —2 purchases, 1 sell
Average closing price · filing quarter
Price range · filing quarter

Every quarterly change

Quarter Action Shares change Est. value change Δ Own Shares held Filing date
Q1 2026 Reduced −176K −66.2% 90K May 15, 2026
Q4 2025 Added +114K +75.5% 265K Feb 13, 2026
Q3 2025 New +151K 151K Nov 13, 2025
Data through Q1 2026 · filed May 15, 2026
3 grouped rows from 3 quarters

More Dalio positions

Common questions

Does Ray Dalio own ADPT?

Yes. As of Q1 2026, Ray Dalio disclosed 90K shares of ADPT, worth an amount we cannot price. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

When did Ray Dalio buy ADPT?

Ray Dalio first disclosed a ADPT position in Q3 2025; every quarterly buy and sell since is in the table above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

Did Ray Dalio sell ADPT?

The quarter-by-quarter table above shows each sale and reduction Ray Dalio disclosed in ADPT. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How many shares of ADPT does Ray Dalio own?

Ray Dalio disclosed 90K shares of ADPT as of Q1 2026. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

What price did Ray Dalio pay for ADPT?

Ray Dalio began building the ADPT position before our 13F history starts, so an exact average buy price cannot be estimated without understating it. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How are the estimated trade prices calculated?

13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.